文献速递细菌感染、耐药与抗菌药物医院感染防控

直接血液细菌检测对急性感染成人抗生素给药的影响:一项随机试验

Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该实用随机试验在急诊科纳入500例接受经验性静脉万古霉素的疑似感染成人,比较直接血液细菌检测联合血培养与单纯血培养。直接检测使病原结果报告时间中位缩短5.2天,但未缩短静脉万古霉素或抗假单胞菌β-内酰胺类抗生素的疗程,临床结局相似。

要点

  • 直接检测使病原结果报告时间中位缩短5.2天。

核心结论

  • 在急诊接受经验性静脉万古霉素的疑似感染成人中,直接血液细菌检测未缩短静脉万古霉素或抗假单胞菌β-内酰胺类抗生素的疗程。

研究设计与样本

  • 2023年12月至2024年12月在一家学术医学中心急诊科开展的实用随机试验,纳入500例接受经验性静脉万古霉素的疑似感染成人。
  • 干预组采用直接血液细菌检测联合血培养,对照组仅采用血培养。
  • 主要结局为随机化至末次静脉万古霉素给药的时间,次要结局为随机化至末次全身抗假单胞菌β-内酰胺类抗生素给药的时间。

主要发现

  • 直接检测组病原结果报告时间中位0.4天(IQR 0.3-0.5),对照组中位5.5天(IQR 5.2-5.6),中位缩短5.2天(95%CI 5.1-5.2)。
  • 临床结局两组相似。

临床怎么用

  • 直接血液细菌检测可更快获得病原结果,但本试验中未因此实现更早的抗生素降阶梯。
  • 对于急诊经验性使用万古霉素的疑似感染成人,不应仅依赖直接检测来缩短抗假单胞菌β-内酰胺类或万古霉素疗程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For hospitalized adults receiving empiric antibiotic therapy, antibiotic de-escalation prevents unnecessary exposure and adverse effects. Whether use of direct-from-blood bacterial testing facilitates earlier antibiotic de-escalation and improves clinical outcomes has never been evaluated in a randomized trial. METHODS: Between December 2023 and December 2024, this pragmatic randomized trial compared direct-from-blood bacterial testing with blood cultures (intervention group) to blood cultures alone (usual care group) in adults with suspected infection receiving empiric intravenous vancomycin in the emergency department of an academic medical center. The primary and secondary outcomes were time from randomization to last dose of intravenous vancomycin and systemic antipseudomonal beta-lactam antibiotics, respectively. RESULTS: Among 500 patients enrolled, the time from randomization to results of bacterial testing from blood (direct-from-blood test, gram stain, or negative culture) was a median of 5.2 days shorter (95% CI, 5.1-5.2) in the direct-from-blood test group (median 0.4 days; IQR, 0.3-0.5) than the usual care group (median, 5.5 days; IQR, 5.2-5.6). The time between randomization and the last dose of intravenous vancomycin did not differ between the direct-from-blood test group (median, 12.5 hours; IQR, 0.79-57.8) and the usual care group (median, 19.0 hours; IQR 0.9-64.8) (HR, 1.08; 95% CI, .90-1.28; P = .42), nor did the time to last dose of systemic antipseudomonal beta-lactam antibiotics (HR, 1.04; 95% CI .87-1.24). Clinical outcomes were also similar. CONCLUSIONS: Among adults with suspected infection receiving empiric intravenous vancomycin in the emergency department, use of direct-from-blood bacterial testing did not shorten the duration of intravenous vancomycin or antipseudomonal beta-lactam antibiotics.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gaston DC, Humphries RM, Lewis AA, et al. Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial. Clin Infect Dis. 2026. PMID: 41537587. doi:10.1093/cid/ciaf677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。